Filter
567
Text search:
variants
Featured
Recommendations
85
New Publications
54
Language
Document type
Guidelines
140
Studies & Reports
127
No document type
127
Fact sheets
56
Strategic & Response Plan
37
Manuals
33
Videos
14
Situation Updates
10
Training Material
9
Resource Platforms
7
Infographics
4
Brochures
3
Countries / Regions
Global
35
Africa
23
Latin America and the Carribbean
17
India
15
Brazil
14
Western and Central Europe
11
Germany
10
Russia
10
Kenya
8
Syria
6
South Africa
6
Nigeria
5
Ethiopia
5
Niger
5
East and Southern Africa
5
West and Central Africa
5
Middle East and North Africa
5
Congo, Democratic Republic of
4
South Sudan
4
Malawi
4
Mozambique
4
Colombia
4
Eastern Europe
4
Senegal
3
Cameroon
3
Uganda
3
Haiti
3
Lebanon
3
Peru
3
Bolivia
3
Myanmar / Burma
3
Chile
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Asia
3
Venezuela
3
Spain
3
Burkina Faso
2
Liberia
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Ghana
2
Philippines
2
Turkey
2
Chad
2
Rwanda
2
Bangladesh
2
Sudan
2
Argentina
2
Ukraine
2
Nicaragua
2
Yemen
2
Kazakhstan
2
France
2
Tunisia
2
Guinea
1
Sierra Leone
1
Saudi Arabia
1
Zimbabwe
1
Somalia
1
Pakistan
1
Iraq
1
Jordan
1
Afghanistan
1
Egypt
1
Tanzania
1
China
1
Indonesia
1
Mauritania
1
Benin
1
Central African Republic
1
Dominican Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Serbia
1
Cuba
1
Honduras
1
Ecuador
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Western Pacific Region
1
Palestine
1
Armenia
1
Southern Africa
1
Congo-Brazzaville
1
Tajikistan
1
Qatar
1
Moldova
1
Uzbekistan
1
Kyrgyzstan
1
Georgia
1
Vietnam
1
Gabon
1
Jamaica
1
United Kingdom
1
Portugal
1
Belarus
1
French Guyana
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
147
Clinical Guidelines
43
Public Health
29
Key Resources
18
Pharmacy & Technologies
15
Women & Child Health
9
Capacity Building
5
Toolboxes
COVID-19
267
Mental Health
34
HIV
25
NTDs
21
Rapid Response
20
TB
16
Planetary Health
16
AMR
15
NCDs
11
Malaria
11
Global Health Education
9
Health Financing Toolbox
9
2.0 Rapid Response
9
Ebola & Marburg
7
Conflict
7
Caregiver
5
Refugee
4
Specific Hazards
4
Pharmacy
4
Cholera
3
Disability
2
Polio
2
Natural Hazards
2
Zika
1
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
Vertreter besorgniserregender Virusvarianten (variants of concern, kurz VOC) wurden weltweit aber auch in Europa, identifiziert. Molekularbiologische Details zu den Varianten sind unter SARS-CoV-2: Virologische Basisdaten und Virusvarianten abrufbar
...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other
...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
coun
...
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and ov
...
The New England Journal of Medicine
Genetic analysis of the virus indicates that it is closely related (97% identical) to variants of Ebola virus (species Zaire ebolavirus) identified earlier in the Democratic Republic of the Congo and Gabon
PLEAS
...
Are the symptoms of COVID-19 different in children? Do the new variants impact children differently? What can parents do to keep children safe from COVID-19. WHO's Dr Maria Van Kerkhove explains in Science in 5.
Science in 5 is WHO’s conversa
...
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decon
...
The number of COVID-19 cases is on the rise again, with South Africa nearing half of all confirmed cases in the WHO African Region. Threats of new variants loom and low vaccination coverage raises questions on the future of the response to COVID-19.
...
Leptospirosis is a zoonotic disease with epidemic potential, especially after a heavy rainfall,
caused by a bacterium called Leptospira. Leptospira interrogans is pathogenic to humans and
animals, with more than 200 serologic variants or serovars.
...
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decon
...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We
...
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and di
...
Annex. This document is an update of a guidance published on 12 July 2021, after the review of new scientific evidence on transmission of SARS-CoV-2 variants of concern (VOC). It contains updated recommendations on the use of masks and respirators
...
Le nombre de cas de COVID-19 augmente à nouveau, l’Afrique du Sud comptant pour près de la moitié de tous les cas confirmés de la Région africaine de l’OMS. La menace de nouveaux variants plane, et la faible couverture vaccinale soulève de
...
Genomic sequencing has been an essential tool in generating virological data, driving the laboratory response, and better understanding the dispersal and evolutionary patterns of SARS-CoV-2. In addition to the characterization of the global circulation patterns, early detection of SARS-CoV-2
...
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decon
...
The GTFCC Laboratory Support for Public Health Surveillance document provides guidelines on using DNA-based molecular techniques for identifying and monitoring Vibrio cholerae strains in cholera outbreaks. It highlights the importance of genetic sequencing for tracking transmission, detecting new
...
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so
...
